The results from Phase 1 of the Troculeucel Clinical Trial demonstrated stable/improved outcomes in 90% of subjects, with no drug-related adverse events following troculeucel therapy. Troculeucel ...
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic a ...
About the Trial TransCode's Phase 1 clinical trial is a multicenter ... is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based ...
No significant safety or dose limiting toxicities reported PK data from Cohorts 1 and 2 consistent with preclinical and Phase 0 trial results BOSTON, Feb. 6 ...
SAB BIO to Host Webinar Discussing Topline Results from Phase 1 Trial of SAB-142 for Type 1 Diabetes
SAB BIO, a clinical-stage biopharmaceutical company, announced it will host a webinar on January 28, 2025, to present topline data from its Phase 1 clinical trial for SAB-142, a novel treatment ...
Clinical trial design is a key aspect of the successful conduct of clinical trials. It involves deciding parameters such as the number of patients, the length of the trial, the comparator arm (in ...
The Phase 1 clinical trial is comprised of two components. In the first component, 72 healthy volunteers have been enrolled in a blinded, randomized, placebo-controlled, staggered, parallel design ...
The Phase 1 study is a multi-center ... The findings will inform the design of subsequent clinical trials. Cytonics, founded in 2006, is a private research and development company focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback